PubMed دسترسی آزاد

HMB supplementation combined with high-intensity functional exercise supports aerobic capacity but not strength in trained and untrained males: a randomized controlled trial.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: β-hydroxy-β-methylbutyrate (HMB) supplementation may support aerobic capacity and isometric strength. Its utility has been studied mainly for 3 g HMB·day-1. Therefore, new and personalized HMB supplementation protocols should be verified. This parallel randomized placebo(PLA)-controlled triple-blind study was designed to evaluate the effects of liquid HMB free acid supplementation during customary training/lifestyle or combined with high-intensity functional training (HIFT) on aerobic fitness, physical capacity, and isometric strength indices following an incremental cycling test (ICT) in trained (TR) and untrained (UTR) males. METHODS: Fifty-three TR (29.1 ± 7.7 years; body mass (BM): 84.8 ± 10.0 kg; FFM: 71.2 ± 8.9 kg) and 37 UTR participants (32.3 ± 7.6 years; BM: 90.1 ± 16.5 kg; FFM: 68.4 ± 10.3 kg) completed two 3-weeks periods, including: 1) supplementation period (SUP)-ingesting 90 mg·kgFFM -1·day-1 of either HMB or PLA and performing usual training (TR) or lifestyle (UTR), and 2) HMB/PLA ingestion combined with the additional HIFT stimuli (2 units per week; SUP + EX). TR_HMB, TR_PLA, UTR_HMB, UTR_PLA groups were analyzed. Testing visits were performed at baseline (T BAS ), and after the SUP (T SUP ) and the SUP + EX (T SUP+EX ). The following evaluations were performed: BM and body composition, ICT, and maximal voluntary isometric contraction (MVIC) of the lower limb. A general linear model was conducted to examine the main effects and interaction of treatment (supplementation) (HMB/PLA), training status (TS; TR/UTR), and baseline values (BAS) over repeated measurements (T BAS , T SUP , T SUP+EX ). The following interactions were tested: visit × treatment; visit × TS; visit × treatment × TS; and visit × treatment × TS × BAS. One-way ANOVA or Kruskal-Wallis ANOVA (non-normal distribution) were conducted to examine differences in the degree of absolute changes (ΔT SUP -T BAS , ΔT SUP+EX -T SUP , ΔT SUP+EX -T BAS ) in the measured indices between studied subgroups. RESULTS: Increases (T SUP+EX -T BAS ) in VO2MAX (p = 0.024), time to the anaerobic threshold (AT; p < 0.001), VO2AT (p = 0.001), power output at the AT (p < 0.001), heart rate at the AT (p < 0.001), time to the respiratory compensation point (RCP; p < 0.001), VO2RCP (p < 0.001), power output at the RCP (p < 0.001) were higher in TR_HMB vs. TR_PLA. Simultaneously, in UTR, greater increases in TimeRCP (p = 0.001) and PowerRCP (p = 0.002) occurred with HMB supplementation compared to PLA. MVIC indices did not change due to the treatment. CONCLUSIONS: Supplementation of high HMB dose combined with HIFT increases aerobic fitness and capacity, especially RCP and AT indices. HMB supplementation combined with HIFT evoked significant favorable changes in a greater number of the evaluated aerobic fitness and capacity indices in trained compared to untrained individuals. Thus, untrained individuals probably need greater exercise stimuli (>2 HIFT units per week) and a longer intervention period to obtained greater benefits. These findings suggest that incorporating liquid HMB supplementation at a dose of 90 mg·kgFFM -1·day-1 alongside HIFT is an effective strategy to enhance aerobic fitness and capacity in trained individuals, while further research including longer intervention periods and greater training stimuli is needed to determine the optimal supplementation protocol for untrained individuals.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Beta-hydroxy beta-methyl butyric acidergogenic supportpersonalized supplementationsports dieteticsβ-hydroxy-β-methylbutyrate
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Dietary intervention through bacterial-derived butyrate elicits anti-tumor activity and increases anti-PD-1 response.

The gut microbiome is increasingly recognized as a key modulator of cancer immunotherapy efficacy. Given that diet is one of the most important determinants of the gut microbiome composition and function, nutritional strategies have emerged as promising tools to modulate anti-tumor immune responses. Here, we demonstrate that dietary supplementation with inulin reduces tumor growth and enhances αPD-1 efficacy in mice. These effects were…

PubMed2026

Lactiplantibacillus plantarum WJL ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet.

Low-protein diets (LPD) are recommended in chronic kidney disease (CKD) to reduce disease progression. However, their clinical efficacy and safety are debated due to the risk of protein-energy wasting. A deeper mechanistic understanding is therefore required. Herein, the metabolic effects of LPD in both murine models and a randomized controlled trial in nondiabetic CKD patients were investigated, focusing on glucose homeostasis, plasma…

PubMed2026

Christensenella massiliensis reduces kynurenine levels and alleviates obesity and related metabolic disorders in model mice.

Next-generation probiotics derived from gut commensals show promise for metabolic disease intervention, yet effective anti-obesity strains remain limited. Here, we demonstrate that oral administration of Christensenella massiliensis markedly alleviates obesity and metabolic dysfunction in high-fat diet-induced obese mice. Treatment reduced food intake, improved glucose tolerance and insulin sensitivity, lowered blood glucose and lipid …

PubMed2026

Parabacteroides distasonis alleviates Clostridioides difficile infection in mice while modulating secondary bile acids.

Clostridioides difficile infection (CDI) is a major cause of antibiotic-associated diarrhea, with frequent recurrences closely linked to antibiotic-induced dysbiosis of the gut microbiota and bile acid metabolism. Parabacteroides distasonis, a potential probiotic capable of converting primary to secondary bile acids, has shown therapeutic promise in several metabolic and inflammatory diseases. This study evaluated the preventive and th…